Chlorine in PDB 8flg: Bruton'S Tyrosine Kinase in Complex with An Orthosteric Inhibitor

All present enzymatic activity of Bruton'S Tyrosine Kinase in Complex with An Orthosteric Inhibitor:
2.7.10.2;

The structure of Bruton'S Tyrosine Kinase in Complex with An Orthosteric Inhibitor, PDB code: 8flg was solved by C.M.Metrick, D.J.Marcotte, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	31.23 / 2.20
Space group	P 21 21 2
Cell size a, b, c (Å), α, β, γ (°)	71.241, 104.24, 38.018, 90, 90, 90
R / Rfree (%)	19.5 / 25.4

The binding sites of Chlorine atom in the Bruton'S Tyrosine Kinase in Complex with An Orthosteric Inhibitor (pdb code 8flg). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Bruton'S Tyrosine Kinase in Complex with An Orthosteric Inhibitor, PDB code: 8flg:

Chlorine binding site 1 out of 1 in the Bruton'S Tyrosine Kinase in Complex with An Orthosteric Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Bruton'S Tyrosine Kinase in Complex with An Orthosteric Inhibitor within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl702 b:40.5 occ:1.00 CL1 A:Y8C702 0.0 40.5 1.0 C16 A:Y8C702 1.7 28.4 1.0 C15 A:Y8C702 2.7 20.1 1.0 C17 A:Y8C702 2.7 24.8 1.0 N A:VAL415 3.5 25.3 1.0 CG2 A:VAL416 3.6 20.0 1.0 C A:GLY414 3.6 36.4 1.0 O A:VAL415 3.7 23.4 1.0 N A:GLY414 3.8 43.4 1.0 CA A:GLY414 3.8 39.1 1.0 O A:MET431 3.9 30.5 1.0 C A:VAL415 3.9 31.0 1.0 CB A:LYS430 3.9 28.1 1.0 C18 A:Y8C702 4.0 18.8 1.0 C14 A:Y8C702 4.0 19.4 1.0 N A:MET431 4.1 23.2 1.0 CA A:LYS430 4.2 24.6 1.0 O A:GLY414 4.2 33.0 1.0 C A:MET431 4.2 28.8 1.0 CA A:VAL415 4.3 30.3 1.0 C A:LYS430 4.3 21.9 1.0 N A:VAL416 4.4 24.5 1.0 C19 A:Y8C702 4.5 17.6 1.0 CG A:LYS430 4.5 24.4 1.0 O A:HOH878 4.6 44.7 1.0 N A:ILE432 4.7 34.8 1.0 CD A:LYS430 4.8 23.9 1.0 CA A:ILE432 4.8 31.0 1.0 CA A:MET431 4.8 26.4 1.0 CB A:VAL416 4.9 22.3 1.0 CA A:VAL416 4.9 26.2 1.0

G.H.Vandeveer, R.M.Arduini, D.P.Baker, K.Barry, T.Bohnert, J.K.Bowden-Verhoek, P.Conlon, P.F.Cullen, B.Guan, T.J.Jenkins, S.Y.Liao, L.Lin, Y.T.Liu, D.Marcotte, E.Mertsching, C.M.Metrick, E.Negrou, N.Powell, D.Scott, L.F.Silvian, B.T.Hopkins. Discovery of Structural Diverse Reversible Btk Inhibitors Utilized to Develop A Novel in Vivo CD69 and CD86 Pk/Pd Mouse Model. Bioorg.Med.Chem.Lett. V. 80 29108 2023.
ISSN: ESSN 1464-3405
PubMed: 36538993
DOI: 10.1016/J.BMCL.2022.129108